Lenvatinib Mesylate and Nevirapine Extended-Release Tablets
Determining the interaction of Lenvatinib Mesylate and Nevirapine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: nevirapine
Brand name: Viramune, Viramune XR
Synonyms: Nevirapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Nevirapine Oral Suspension
- Lenvatinib Mesylate-Nevirapine Suspension
- Lenvatinib Mesylate-Nevirapine Tablets
- Lenvatinib Mesylate-New Day
- Lenvatinib Mesylate-New Terocin
- Lenvatinib Mesylate-Nexa Plus
- Nevirapine Extended-Release Tablets-Lenvima
- Nevirapine Extended-Release Tablets-Lenvima (14 MG Daily Dose)
- Nevirapine Extended-Release Tablets-Lenvima (18 MG Daily Dose)
- Nevirapine Extended-Release Tablets-Lenvima (20 MG Daily Dose)
- Nevirapine Extended-Release Tablets-Lenvima (24 MG Daily Dose)
- Nevirapine Extended-Release Tablets-Lenvima (8 MG Daily Dose)